Circulating Tumour Cells (CTCs) in NSCLC: From Prognosis to Therapy Design

KEJIK, Z., R. KAPLANEK, P. DYTRYCH, M. MASARIK, K. VESELA, N. ABRAMENKO, D. HOSKOVEC, M. VASAKOVA, J. KRALOVA, P. MARTASEK, M. JAKUBEK
Circulating Tumour Cells (CTCs) in NSCLC: From Prognosis to Therapy Design. Pharmaceutics. 2021, 13(11), 1879, ISSN: 1999-4923 , PMID: 34834295,